Indapamide 2.5mg Sustained-Release Tablets from Japan
Indapamide is a thiazide-like diuretic with vasodilatory properties for essential hypertension treatment. HTS 3004.90.92.63 covers this measured-dose, sustained-release form affecting caloric and electrolytic balance, packaged for retail sale. Designed for once-daily patient administration.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Submit extended-release dissolution testing results for FDA import review
• Label with lipid metabolism effect disclosures for this diuretic class
• Confirm controlled-release mechanism qualifies as measured-dose product